Antiandrogens in prostate cancer

The European School of Oncology was established to address the need for information, education, and training in cancer diagnosis and treatment. This initiative arose from two main challenges: the necessity for a multidisciplinary approach in oncology education, which universities struggle to implement due to their disciplinary focus, and the rapid technological advancements in cancer treatment that medical faculties find difficult to incorporate into their curricula. Through residential courses on organ pathologies and seminars covering new techniques (such as laser therapy, monoclonal antibodies, and imaging) as well as major therapeutic debates (like conservative versus mutilating surgery and the roles of chemotherapy and radiotherapy), the European School of Oncology aims to bridge the cultural and scientific divide between academia, industry, and everyday medical practice. A recent initiative includes the establishment of permanent study groups, or task forces, where a select group of leading experts convenes annually to define the current state of oncology and potentially reach a consensus on future developments in specific areas.